Search Results - "van der Eb, M M"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells by GEUTSKENS, S. B, VAN DER EB, M. M, PLOMP, A. C, JONGES, L. E, CRAMER, S. J, ENSINK, N. G, KUPPEN, P. J. K, HOEBEN, R. C

    Published in Gene therapy (01-08-2000)
    “…The host-immune response against adenoviruses forms a major obstacle for their use as gene therapy vectors for treatment of genetic defects. None the less,…”
    Get full text
    Journal Article
  2. 2

    Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration by VAN DER EB, M. M, CRAMER, S. J, VERGOUWE, Y, SCHAGEN, F. H. E, VAN KRIEKEN, J. H. J. M, VAN DER EB, A. J, RINKES, I. H. M. B, VAN DE VELDE, C. J. H, HOEBEN, R. C

    Published in Gene therapy (01-04-1998)
    “…The use of so-called 'suicide' genes to activate prodrugs has been effective in animal models for several solid tumor types and is now in phase I and II…”
    Get full text
    Journal Article
  3. 3

    Specific tumor-cell killing with adenovirus vectors containing the apoptin gene by Pietersen, A M, van der Eb, M M, Rademaker, H J, van den Wollenberg, D J, Rabelink, M J, Kuppen, P J, van Dierendonck, J H, van Ormondt, H, Masman, D, van de Velde, C J, van der Eb, A J, Hoeben, R C, Noteborn, M H

    Published in Gene therapy (01-05-1999)
    “…Specificity is an essential prerequisite for cancer gene therapy. Recently we described that apoptin, a protein of 121 amino acids which is derived from the…”
    Get full text
    Journal Article
  4. 4

    Gene therapy with Apoptin induces regression of xenografted human hepatomas by van der Eb, Marjolijn M, Pietersen, Alexandra M, Speetjens, Frank M, Kuppen, Peter J K, van de Velde, Cornelis J H, Noteborn, Mathieu H M, Hoeben, Rob C

    Published in Cancer gene therapy (01-01-2002)
    “…The chicken anemia virus-derived Apoptin protein shows remarkable specificity; namely, it induces apoptosis in tumor cells, but not in normal diploid cells. We…”
    Get full text
    Journal Article
  5. 5

    Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer by Kuppen, P J, van der Eb, M M, Jonges, L E, Hagenaars, M, Hokland, M E, Nannmark, U, Goldfarb, R H, Basse, P H, Fleuren, G J, Hoeben, R C, van de Velde, C J

    Published in Histochemistry and cell biology (01-01-2001)
    “…In this article we report about the role that tumor structure and extracellular matrix (ECM) may play in immunotherapy and in gene therapy using adenoviruses…”
    Get full text
    Journal Article
  6. 6

    Isolated-organ perfusion for local gene delivery : efficient adenovirus-mediated gene transfer into the liver by DE ROOS, W. K, FALLAUX, F. J, MARINELLI, A. W. K. S, LAZARIS-KARATZAS, A, ALTING VON GEUSAU, B, VAN DER EB, M. M, CRAMER, S. J, TERPSTRA, O. T, HOEBEN, R. C

    Published in Gene therapy (1997)
    “…Targeted gene delivery is essential for gene therapy involving in vivo gene transfer. In the present study we analyzed the efficiency and tissue-specificity of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Reverse smoking as a risk factor for palatal cancer: a cross-sectional study in rural Andhra Pradesh, India by van der Eb, M M, Leyten, E M, Gavarasana, S, Vandenbroucke, J P, Kahn, P M, Cleton, F J

    Published in International journal of cancer (09-07-1993)
    “…A cross-sectional study of reverse smoking and its association with pre-malignant and malignant lesions of the palate was conducted in the north coastal areas…”
    Get more information
    Journal Article
  9. 9

    Factors impeding efficient expression of factor VIII complementary DNA minigenes by Hoeben, R C, Fallaux, F J, Schagen, F H, van der Eb, M M, van Ormondt, H, van der Eb, A

    Published in Blood coagulation & fibrinolysis (01-12-1997)
    “…Haemophilia A is a bleeding disorder that affects approximately 1 in 10,000 males. It is caused by a deficiency of functional blood-clotting factor VIII…”
    Get more information
    Journal Article
  10. 10

    Towards gene therapy for colorectal liver metastases by van der Eb, M M, Hoeben, R C, van de Velde, C J

    Published in Recent results in cancer research (1998)
    “…Hepatic gene therapy may provide a new approach to treating hepatic malignancies. A promising strategy involves the infection of tumor and liver cells with…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Saccular Abdominal Aortic Aneurysms: Patient Characteristics, Clinical Presentation, Treatment, and Outcomes in the Netherlands by Karthaus, Eleonora G, Tong, Thaïs M L, Vahl, Anco, Hamming, Jaap F

    Published in Annals of surgery (01-11-2019)
    “…OBJECTIVE:The aim of this was to analyze differences between saccular-shaped abdominal aortic aneurysms (SaAAAs) and fusiform abdominal aortic aneurysms…”
    Get full text
    Journal Article
  13. 13

    Delivery of anticancer drugs via isolated hepatic perfusion: A promising strategy in the treatment of irresectable liver metastases? by Vahrmeijer, Alexander L., van der Eb, Marjolijn M., van Dierendonck, Jan Hein, Kuppen, Peter J. K., van de Velde, Cornelis J. H.

    Published in Seminars in surgical oncology (01-04-1998)
    “…The prognosis of patients with irresectable liver metastases derived from colorectal cancer is invariably poor; unfortunately, these tumours show only minor…”
    Get full text
    Journal Article
  14. 14

    Nationwide Analysis of Patients Undergoing Iliac Artery Aneurysm Repair in the Netherlands by Jalalzadeh, Hamid, Indrakusuma, Reza, Koelemay, Mark J W, Balm, Ron, Van den Akker, L H, Van den Akker, P J, Akkersdijk, G J, Akkersdijk, G P, Akkersdijk, W L, van Andringa de Kempenaer, M G, Arts, C H, Avontuur, J A, Baal, J G, Bakker, O J, Balm, R, Barendregt, W B, Bender, M H, Bendermacher, B L, van den Berg, M, Berger, P, Beuk, R J, Blankensteijn, J D, Bleker, R J, Bockel, J H, Bodegom, M E, Bogt, K E, Boll, A P, Booster, M H, Borger van der Burg, B L, de Borst, G J, Bos-van Rossum, W T, Bosma, J, Botman, J M, Bouwman, L H, Breek, J C, Brehm, V, Brinckman, M J, van den Broek, T H, Brom, H L, de Bruijn, M T, de Bruin, J L, Brummel, P, van Brussel, J P, Buijk, S E, Buimer, M G, Burger, D H, Buscher, H C, den Butter, G, Cancrinus, E, Castenmiller, P H, Cazander, G, Coveliers, H M, Cuypers, P H, Daemen, J H, Dawson, I, Derom, A F, Dijkema, A R, Diks, J, Dinkelman, M K, Dirven, M, Dolmans, D E, van Doorn, R C, van Dortmont, L M, van der Eb, M M, Eefting, D, van Eijck, G J, Elshof, J W, Elsman, B H, van der Elst, A, van Engeland, M I, van Eps, R G, Faber, M J, de Fijter, W M, Fioole, B, Fritschy, W M, Geelkerken, R H, van Gent, W B, Glade, G J, Govaert, B, Groenendijk, R P, de Groot, H G, van den Haak, R F, de Haan, E F, Hajer, G F, Hamming, J F, van Hattum, E S, Hazenberg, C E, Hedeman Joosten, P P, Helleman, J N, van der Hem, L G, Hendriks, J M, van Herwaarden, J A, Heyligers, J M, Hinnen, J W, Hissink, R J, Ho, G H, den Hoed, P T, Hoedt, M T, van Hoek, F, Hoencamp, R

    “…The new 2019 guideline of the European Society for Vascular Surgery (ESVS) recommends consideration for elective iliac artery aneurysm (eIAA) repair when the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Short-term outcomes of open surgical abdominal aortic aneurysm repair from the Dutch Surgical Aneurysm Audit by Geraedts, A C M, Alberga, A J, Koelemay, M J W, Verhagen, H J M, Vahl, A C, Balm, R

    Published in BJS open (01-10-2021)
    “…The sharp decrease in open surgical repair (OSR) for abdominal aortic aneurysm (AAA) has raised concerns about contemporary postoperative outcomes. The study…”
    Get full text
    Journal Article
  17. 17

    Gene therapy for hemophilia: feasible in principle but not yet clinically applicable by van der Eb, M M, Schagen, F H, van Ormondt, H, Hoeben, R C

    Published in Nederlands tijdschrift voor geneeskunde (11-04-1998)
    “…The current treatment of haemophiliacs consists of injection of concentrates of blood clotting factors VIII (haemophilia A) and IX (haemophilia B). The…”
    Get more information
    Journal Article